Chronic Kidney Disease Among COVID-19 Patients Admitted in the Department of Medicine of a Tertiary Care Centre: A Descriptive Cross-sectional Study

Overview

Journal JNMA J Nepal Med Assoc

Specialty General Medicine

Date 2023 May 19

PMID 37203886

Authors

Milan Khadka

Lochan Karki

Rama Tamrakar

Milan Purna Oli

Santosh Joti

Suman Khatri

Siddhant Adhikari

Shrinkhala Maharjan

Poonam Kc

Affiliations

Soon will be listed here.

Abstract

Introduction: Comorbidities are frequently seen in admitted COVID-19 patients most common being hypertension, diabetes, cardiovascular diseases and chronic kidney disease. Chronic kidney disease is a slowly progressive chronic illness due to the gradual loss of kidney function or structure. The available data regarding the prevalence of chronic kidney disease and COVID-19 comorbidities is still limited. The aim of this study was to find out the prevalence of chronic kidney disease among COVID-19 patients admitted to the Department of Medicine of a tertiary care centre.

Methods: A descriptive cross-sectional study was done in the Department of Medicine of a tertiary care centre. Data of medical records between 1 August 2020 to 1 December 2022 were reviewed retrospectively. The data was collected from 20 January 2023 to 20 March 2023. Ethical approval was obtained from the Institutional Review Committee (Reference number: 646/2079/80). Data on chronic kidney disease patients among COVID-19 patients were collected from the hospital records. Convenience sampling method was used. Point estimate and 95% Confidence Interval were calculated.

Results: Among 584 COVID-19 patients admitted, the prevalence of chronic kidney disease was 43 (7.36%) (5.24-9.48, 95% Confidence Interval). A total of 30 (69.77%) were male and 13 (30.23%) were female with a mean age of 55±16.22 years.

Conclusions: The prevalence of chronic kidney disease among COVID-19 patients admitted in the department of Medicine of a tertiary care centre was found to be slightly higher than other studies done in similar settings.

Keywords: chronic kidney disease; COVID-19; prevalence; tertiary care centre.

References

Khan Chachar A, Khan K, Khan A, Muhammad Imran Hasan K, Ashraf Zia M, Siddique N . Clinical and Demographic Characteristics Including Comorbidities and Their Outcomes Among Patients Hospitalized With COVID-19 in Four Tertiary Care Hospitals Across Lahore. Cureus. 2021; 13(1):e12663. PMC: 7880821. DOI: 10.7759/cureus.12663. View

Suleyman G, Fadel R, Malette K, Hammond C, Abdulla H, Entz A . Clinical Characteristics and Morbidity Associated With Coronavirus Disease 2019 in a Series of Patients in Metropolitan Detroit. JAMA Netw Open. 2020; 3(6):e2012270. PMC: 7298606. DOI: 10.1001/jamanetworkopen.2020.12270. View

Wang D, Hu B, Hu C, Zhu F, Liu X, Zhang J . Clinical Characteristics of 138 Hospitalized Patients With 2019 Novel Coronavirus-Infected Pneumonia in Wuhan, China. JAMA. 2020; 323(11):1061-1069. PMC: 7042881. DOI: 10.1001/jama.2020.1585. View

Ammirati A . Chronic Kidney Disease. Rev Assoc Med Bras (1992). 2020; 66Suppl 1(Suppl 1):s03-s09. DOI: 10.1590/1806-9282.66.S1.3. View

Guan W, Liang W, Zhao Y, Liang H, Chen Z, Li Y . Comorbidity and its impact on 1590 patients with COVID-19 in China: a nationwide analysis. Eur Respir J. 2020; 55(5). PMC: 7098485. DOI: 10.1183/13993003.00547-2020. View

Sato R, Matsuzawa Y, Ogawa H, Kimura K, Tsuboi N, Yokoo T . Chronic kidney disease and clinical outcomes in patients with COVID-19 in Japan. Clin Exp Nephrol. 2022; 26(10):974-981. PMC: 9164570. DOI: 10.1007/s10157-022-02240-x. View

Atkins J, Masoli J, Delgado J, Pilling L, Kuo C, Kuchel G . Preexisting Comorbidities Predicting COVID-19 and Mortality in the UK Biobank Community Cohort. J Gerontol A Biol Sci Med Sci. 2020; 75(11):2224-2230. PMC: 7454409. DOI: 10.1093/gerona/glaa183. View

Hussain M, Iltaf Sr S, Salman Sr S, Ghuman F, Abbas S, Fatima M . Frequency of Comorbidities in Admitting COVID-19 Pneumonia Patients in a Tertiary Care Setup: An Observational Study. Cureus. 2021; 13(2):e13546. PMC: 8007124. DOI: 10.7759/cureus.13546. View

Kunutsor S, Laukkanen J . Renal complications in COVID-19: a systematic review and meta-analysis. Ann Med. 2020; 52(7):345-353. PMC: 7877945. DOI: 10.1080/07853890.2020.1790643. View

10.

Koyyada R, Nagalla B, Tummala A, Singh A, Patnam S, Barigala R . Prevalence and Impact of Preexisting Comorbidities on Overall Clinical Outcomes of Hospitalized COVID-19 Patients. Biomed Res Int. 2022; 2022:2349890. PMC: 8984738. DOI: 10.1155/2022/2349890. View

11.

Abrishami A, Khalili N, Dalili N, Khaleghnejad Tabari R, Farjad R, Samavat S . Clinical and Radiologic Characteristics of COVID-19 in Patients With CKD. Iran J Kidney Dis. 2020; 14(4):267-277. View

12.

Akchurin O, Meza K, Biswas S, Greenbaum M, Licona-Freudenstein A, Goyal P . COVID-19 in Patients with CKD in New York City. Kidney360. 2021; 2(1):63-70. PMC: 7901833. DOI: 10.34067/KID.0004142020. View

13.

Carter L, Garner L, Smoot J, Li Y, Zhou Q, Saveson C . Assay Techniques and Test Development for COVID-19 Diagnosis. ACS Cent Sci. 2020; 6(5):591-605. PMC: 7197457. DOI: 10.1021/acscentsci.0c00501. View

14.

Barbu M, Thompson R, Thompson D, Cretoiu D, Suciu N . The Impact of SARS-CoV-2 on the Most Common Comorbidities-A Retrospective Study on 814 COVID-19 Deaths in Romania. Front Med (Lausanne). 2020; 7:567199. PMC: 7509043. DOI: 10.3389/fmed.2020.567199. View